The table below shows TEVA PHARMACEUTICAL INDUSTRIES LTD's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$17.26B
$16.54B
$15.85B
$14.93B
$15.88B
$16.66B
Cost of revenue
$8.32B
$8.48B
$8.20B
$7.95B
$8.28B
$8.93B
Gross profit
$8.94B
$8.06B
$7.64B
$6.97B
$7.59B
$7.73B
R&D
-
-
-
$98.00M
-
-
SG&A
TEVA annual revenue (10-K history)
TEVA PHARMACEUTICAL INDUSTRIES LTD reported annual revenue of $17.26B for fiscal year 2025. That is up 4.3% from $16.54B in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $21.90B (FY 2016) to $17.26B. Figures come from the company's audited annual reports as filed with the SEC.
